Clinton To PhRMA: If You Don't Like Obama Targeting Drug Costs, Find An Alternative
This article was originally published in The Pink Sheet Daily
Former President Bill Clinton talked budgets and deficit reduction at the PhRMA annual meeting April 14.
You may also be interested in...
President Obama's deficit reduction framework borrows ideas from previous spending documents such as the 2012 budget and the fiscal commission report in its cost-cutting recommendations for Medicare.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.